Physician profile
Lori Church
NPI 1164466827
$5,265.28
in general payments reported to CMS, 2019-2025
25 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $372 · 2021: $335 · 2022: $300 · 2023: $1,203 · 2024: $971 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,485.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,468.77 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $873.17 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Abbvie INC. | $871.60 | 2022-2025 | Ubrelvy, Vraylar, Qulipta |
| Lilly USA, LLC | $601.86 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.43 | 2019-2024 | Jardiance, Synjardy |
| Novo Nordisk INC | $357.23 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $124.78 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.65 | 2024-2025 | Trintellix |
| Pfizer INC. | $87.95 | 2019-2022 | |
| Amgen INC. | $55.56 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $38.23 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $34.64 | 2020-2021 | |
| Seqirus USA INC | $33.74 | 2021-2024 | Fluad, Flucelvax |
| Phathom Pharmaceuticals, INC. | $32.14 | 2024-2025 | Voquezna |
| Allergan, INC. | $23.93 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.60 | 2022 | |
| Exact Sciences Corporation | $15.42 | 2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $15.31 | 2020 | |
| Genentech USA, INC. | $14.71 | 2020 | |
| Medtronic, INC. | $13.64 | 2025 | Intellis Adaptivestim |
| Sanofi Pasteur INC. | $12.95 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.67 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.14 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.95 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Church listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.